Data protection Impressum

Pharma

The Lausanne University Hospital (CHUV) has secured market authorization from Swissmedic to produce a fecal microbiota transplant (FMT) medication, making it the first accredited center in Switzerland to manufacture this treatment under strict pharmaceutical standards. This breakthrough provides an effective solution for patients suffering from recurrent Clostridioides difficile infections, a debilitating condition characterized by repeated digestive blowouts and severe discomfort.

CHUV becomes first Swiss hospital to produce gut-balancing medication

29 January 2025

EPFL Innovation Park biotech company AB2 Bio has signed an option and licensing agreement with Japan-based Nippon Shinyaku to advance Tadekinig alfa, a novel treatment for Primary Monogenic IL-18 driven Hyperinflammatory Syndrome. The deal includes up to USD 36 million in early payments and milestone-based funding of up to USD 650 million.

AB2 Bio secures USD 650 million partnership with Nippon Shinyaku for rare disease therapy

27 January 2025

To meet the growing demand for hybrid expertise at the crossroads of life sciences and digital technologies, HES-SO Valais-Wallis has introduced a pioneering specialization in Digital Life Sciences, the first of its kind in Western Switzerland.

HES-SO introduces the first Digital Life Sciences program in Western Switzerland

10 December 2024

VÊPRES, the French cleanroom specialist, is setting up in Thônex in the canton of Geneva under the name Vêpres Suisse, marking a new stage in its international development to meet the growing demand for controlled atmosphere environments.

Cleanroom specialist VÊPRES establishes a subsidiary in Thônex

9 December 2024

Biopôle, the renowned life sciences campus in Epalinges-Lausanne, celebrates 20 years of groundbreaking achievements with the inauguration of the Leucine Building.

Biopôle celebrates 20 years of innovation with the inauguration of the Leucine building

9 December 2024

Siegfried, a prominent Swiss Contract Development and Manufacturing Organization (CDMO), has unveiled its new global Research and Development (R&D) center at its site in Evionnaz, in the canton of Valais.

Siegfried has inaugurated its global R&D center in Evionnaz

4 December 2024

Top Stories Western Switzerland

Top Stories from Western Switzerland (November 2024)

26 November 2024

Lonza strengthens its bioconjugation capabilities in Visp with two major expansions, adding three new suites and creating 300 jobs to meet growing demand.

Lonza expands bioconjugation capacity in Visp and creates 300 jobs

12 November 2024

Swissmedic, Switzerland's national regulatory authority for therapeutic products, has strengthened its role in the global healthcare landscape through strategic collaborations and innovations in regulatory science. From cross-border initiatives to advances in digital transformation, Swissmedic is positioning itself as a leader in efficient, high-quality regulatory processes, providing Swiss patients with safe and timely access to cutting-edge therapies.

Swissmedic reinforces Switzerland’s role in global regulatory collaboration and advanced therapeutics

11 November 2024

Ikerian has raised USD 8 million in Series B funding to advance Discovery CONNECT, a platform that optimizes data management in ophthalmology clinics. Lead investor Sanoptis has entered a strategic partnership to distribute the platform across its European network.

Ikerian secures USD 8 million and a strategic partnership with Sanoptis

29 October 2024

1 2 3 4 5 … 13